Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Saturday, October 24, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Kite to Acquire Interius BioTherapeutics in $350 Million Deal to Advance In Vivo CAR T Platform
Life Sciences Times
-
August 21, 2025
0
Venture Capital
EliseAI Raises $250M in Series E to Expand AI Solutions in Healthcare and Housing
Life Sciences Times
-
August 20, 2025
0
Venture Capital
PharmaCyte Biotech Raises $7 Million in Private Placement Led by Existing Investors
Life Sciences Times
-
August 18, 2025
0
Venture Capital
Vyome Launches Strategic Review of Livechain Stake
Life Sciences Times
-
August 18, 2025
0
Venture Capital
SetPoint Medical Secures $140 Million to Advance Rheumatoid Arthritis Therapy, Expands Leadership Team
Life Sciences Times
-
August 11, 2025
0
Venture Capital
Apreo Health Raises $130 Million in Series B to Advance Trial and Commercialization of Novel Emphysema Device
Life Sciences Times
-
August 7, 2025
0
Venture Capital
Strand Therapeutics Secures $153 Million in Series B to Accelerate Programmable mRNA Therapy Pipeline
Life Sciences Times
-
August 7, 2025
0
Venture Capital
AVS Bio Acquires IPA Europe to Boost Antibody Discovery and Protein Production Capabilities
Life Sciences Times
-
August 6, 2025
0
Venture Capital
Frazier Life Sciences Closes $1.3 Billion Fund to Back Early-Stage Biotech Ventures
Life Sciences Times
-
July 31, 2025
0
Venture Capital
Silversmith Capital Partners Closes $1.7 Billion Fund V, Names Sri Rao Managing Partner
Life Sciences Times
-
July 31, 2025
0
Venture Capital
Pahr Therapeutics Secures $14 Million Seed Funding to Develop Novel Pulmonary Arterial Hypertension Therapies
Life Sciences Times
-
July 29, 2025
0
Venture Capital
Omega Funds Closes $647 Million Oversubscribed Fund to Back Life Sciences Innovation
Life Sciences Times
-
July 21, 2025
0
1
...
11
12
13
...
115
Page 12 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026